The Illusion of Corporate Responsibility
THE ACTORS: Who is involved in this story? Bayer AG (formerly Monsanto): The German pharmaceutical and life sciences company acquired Monsanto in 2018 for $63 billion. They are the primary actor, facing thousands of lawsuits concerning glyphosate-based herbicides. Plaintiffs (Farmers, landscapers, gardeners): Individuals diagnosed with non-Hodgkin lymphoma and other cancers, asserting a direct
link to exposure to these pesticides. Legal Teams: Aggressive plaintiff attorneys who have successfully won multi-million dollar verdicts against the company (e.g., the 2018 Johnson v. Monsanto verdict where Dewayne Johnson was awarded $289 million, later reduced). Regulators (EPA, WHO): The U.S. Environmental Protection Agency continues to maintain that glyphosate is not likely carcinogenic to
humans, directly contradicting the World Health Organization's International Agency for Research on Cancer (IARC), which classified glyphosate as 'probably carcinogenic to humans' in 2015. This regulatory dichotomy fuels legal battles. THE FUNDING: Where does their money come from? Bayer AG: Global revenues exceeding €47 billion in 2021, with Crop Science (their agricultural division, which
includes former Monsanto products) contributing significantly. The cost of litigation settlements is a direct drain on these profits. The company has already earmarked over $16 billion for settlements related to glyphosate lawsuits (Company filings, 2020). Plaintiffs' Legal Teams: Operate on contingency fees, meaning they only get paid if they win, incentivizing them to pursue cases with strong